Amundi CAC Transition Climat UCITS ETF (X13J)

Able to discern

Folks adding just in case, no one knows dates

Yes, 18 YRS PLUS IS THE TELL🫵

https://investorshub.advfn.com/uimage/uploads/2026/7/8/ogrrx1_-_Delay_is_evidence.png

2 Definitions of the word "Proprietary":

BIEI / HGI Has told us many times in their PR's They have Proprietary Exclusive Hemp Graphene Biomass Technology that can be used for the Aerospace Industry, Electonics and Energy....This is what they said in a previous PR Below!! Also look at

$CYBL .0013???THAT DOG OTCN KEEPS DILUTING.I SAID TO STOP DILUTING.HE KEEPS ON DOING IT.DOES NOT LET HER BREATHE.LISTEN SUCKER,DO NOT MAKE ME TRADE IT FOR A CAN OF SODA.STARTING TOMORROW IF I SEE OTCN ON THE OFFER,OR HITTING THE BIDS,
WE WILL STAY DOWN UNTIL THE END OF TIME.
$CYBL .00

Fair enough. 
Although I think this point actually puts the whole "just wait till the COB approval before significant price moves" argument to rest. Today proved that even if a change of business was approved it would have little impact on the immediate SP. Guess we're waiting for revenue.

Today's volume was lighter than usual,

trading 754,039 shares, versus an average of 15,409,920 shares per day during the last twelve months. The On Balance Volume indicator (OBV) is bullish. The slope of the indicator is positive and suggests that buyers are presently more active tha

lol...stop it. :)

Wow...seriously. Where is everybody that listened to the pitch tonight? No game man. Weak.

Ugh I want tomorrow to come and hope for good news but I don't want it to come because I doubt it will occur

The reality behind the PR Spin...

Yes, this press release exhibits typical biotech PR "spin," though it is based on legitimate statistical methods.
The core spin is framing a post-hoc (after-the-fact) data-reanalysis as an upgraded proof of efficacy, using it to argue that the

Hope you were right, I have an order in for a few.

Gloo Announces Pricing of Public Offering of Class A Common StockJuly 8, 2026 11:30 PM
Business Wire Gloo Holdings, Inc. (Nasdaq: GLOO), a leading technology platform for the faith and flourishing ecosystem, today announced the pricing of its previously announced underwritten p

Going down in heavy volume. Not a good sign . Looking at low $5’s by Friday. Rumor is spreading about conversation rate . No reason to hold (FNMA) with share cancellation possibility. If one has to own shares probably best to sell and wait for IPO for fresh start. There will be no financial advantag

Wow QS Energy is mixing with the big boys of the oil & gas industry. Laksel are well known around the world in the oil industry. Check out their web site

https://www.laksel.com.sg/our_profile.html


The SHORT SQUEEZE will be fun to watch. INDIA want 150 PROVE

$SRXH HIT $2.50 HIGH TODAY FROM .96 LOW A.M, MY TIMING WAS PERFECT.
LOOK WHERE I WAS LOADING. LOL.
07/08/2026
Buy

SRXH SRX GLOBAL INC 10,000 $1.0798 -$10,797.92 More
07/08/2026
Buy

SRXH SRX GLOBAL INC 10,000 $1.1699 -$11,699.00 More

LP has already taken the dilution lifeboats and left you all to sink. All that is left for investors is hopeful desperation, I'm afraid.

Such a shame tbh,

ALERT..PER Q1 REPORT,ON OTC $BCDS HAS A Stockholders' Equity $13,200,301,162 DIVIDE THAT TO 915,812,392 SHARES=BOOK VALUE OF $14.4 PER SHARES.THE STOCK IS AT .017S??IMAGINE IF THIS RUNS TO $14.4 PER SHARE????OMG.

Definium Therapeutics / DFTX: Interesting MOA Advisory Board Breadcrumb

Found another small but potentially meaningful public breadcrumb for Definium Therapeutics.

A public Cvent page shows a “Definium Therapeutics MOA Advisory Board” scheduled for July 8–9, 2026 in Mon

I believe so.

Basing MY assumption on a CRASH and one that mimics the 1929 one we should have a 40-trading day crash from top to bottom. TOP established June 2nd. Places July 28th as the estimated CRASH date. The last 10 to 13 days before the CRASH should also show tension with no ability to rally. it should al

Well, I don't know what to say. If ANIP contracts with a guy running a one-person company out of his house and then loses the first lawsuit against him, what chances do we have that they can pull off a contract for Libigel or spend $100Ms of dollars on any new rare disease acquisition. What the heck

My bad... here is the post from the author of the blog where this came from:

https://x.com/Josh__Hardman/status/2074886266743615986